Bethlehem, PA (GLOBE NEWSWIRE) - CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare & Medicaid Services- Clinical Laboratory Improvement Amendment Survey and Certificate Group) qualifying CeGaT to operate in 49 states or districts in the USA. CeGaT’s subsidiary B. Braun CeGaT, LLC, based in Pennsylvania, is responsible for North American operations.
In addition to the 48 states included previously, CeGaT has now received the CLIA license for California (#CDS00800902). We are excited to provide world-class genetic testing and diagnostics to customers in California.
Beyond CLIA and CAP, CeGaT is accredited according to DIN EN ISO 15189:2014. The company’s portfolio now comprises all significant accreditations and certifications necessary to distribute its human genetics services around the globe.
CeGaT GmbH, Tübingen (Germany), was founded by Saskia Biskup, MD, PhD, and Dirk Biskup, PhD, in 2009. The basis of CeGaT’s success is an established high-throughput process for the use of next generation sequencing (NGS) in diagnostic testing and the up-to-date knowledge of hereditary genetic diseases. CeGaT is a diagnostics company which is renowned for identifying the pathogenic gene variations in patients. Single gene testing (which was state-of-the-art until 2010) would not detect the causative gene variation in 80-90% of all cases. Consequently, CeGaT has invented and established Diagnostic Panels. By simultaneously sequencing all genes associated with a certain disease using next generation sequencing platforms, the probability of finding the causative gene variation is extremely high. In addition, this approach is faster and considerably less expensive than classical gene-by-gene sequencing. CeGaT has more than 120 employees and a subsidiary company B. Braun CeGaT, LLC in the United States. CeGaT also is involved in the following companies: CeMeT GmbH (Center for Metagenomics), CAG GmbH (Center for Animal Genetics) and Cenata GmbH (prenatal diagnosis).
© 2019 GlobeNewswire, Inc. All Rights Reserved.
SOURCE: B. Braun CeGaT, LLC